116 related articles for article (PubMed ID: 7121200)
1. The role of non-critical binding proteins in the sensitivity of acetylcholinesterase from different species to diisopropyl fluorophosphate (DFP), in vitro.
Wang C; Murphy SD
Life Sci; 1982 Jul; 31(2):139-49. PubMed ID: 7121200
[TBL] [Abstract][Full Text] [Related]
2. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
3. Binding of 125I-fasciculin to rat brain acetylcholinesterase. The complex still binds diisopropyl fluorophosphate.
Marchot P; Khélif A; Ji YH; Mansuelle P; Bougis PE
J Biol Chem; 1993 Jun; 268(17):12458-67. PubMed ID: 8509385
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of the species-selective inhibition of brain acetylcholinesterase.
Kemp JR; Wallace KB
Toxicol Appl Pharmacol; 1990 Jun; 104(2):246-58. PubMed ID: 2363176
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):295-310. PubMed ID: 2256118
[TBL] [Abstract][Full Text] [Related]
6. The aryl acylamidase activity is much more sensitive to Alzheimer drugs than the esterase activity of acetylcholinesterase in chicken embryonic brain.
Rajesh RV; Chitra L; Layer PG; Boopathy R
Biochimie; 2009 Sep; 91(9):1087-94. PubMed ID: 19607873
[TBL] [Abstract][Full Text] [Related]
7. Correlation of binding sites for diisopropyl phosphorofluoridate with cholinesterase and neuropathy target esterase in membrane and cytosol preparations from hen.
Kamata R; Saito S; Suzuki T; Takewaki T; Kobayashi H
Neurotoxicology; 2001 Apr; 22(2):203-14. PubMed ID: 11405252
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of inhibition of brain and red blood cell acetylcholinesterase and plasma cholinesterase by acephate or methamidophos.
Singh AK
Toxicol Appl Pharmacol; 1985 Nov; 81(2):302-9. PubMed ID: 4060156
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of binding sites for diisopropyl phosphorofluoridate in membrane and cytosol preparations from spinal cord and brain of hens.
Kamata R; Saito SY; Suzuki T; Takewaki T; Kofujita H; Ota M; Kobayashi H
Neurotoxicology; 2001 Apr; 22(2):191-202. PubMed ID: 11405251
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo action of diisopropylfluorophosphate, of atropine and their synergism on acetylcholinesterase activity.
Molinengo L; Ghi P
Pharmacology; 1989; 39(3):154-9. PubMed ID: 2587621
[TBL] [Abstract][Full Text] [Related]
12. Characterization of high-affinity binding sites for diisopropylfluorophosphate (DFP) from chicken spinal cord membranes.
Konno N; Suzuki N; Horiguchi H; Fukushima M
Biochem Pharmacol; 1994 Nov; 48(11):2073-9. PubMed ID: 7802697
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
14. Variation of commercial diisopropyl fluorophosphate preparations in toxicological studies.
Ho IK; Hoskins B
Drug Chem Toxicol; 1983; 6(5):421-7. PubMed ID: 6628264
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rat brain acetylcholinesterase.
Volpe MT; Bisso GM; Michalek H
Neurochem Res; 1990 Oct; 15(10):975-9. PubMed ID: 2077431
[TBL] [Abstract][Full Text] [Related]
16. Molecular properties and inhibition kinetics of acetylcholinesterase obtained from rat brain and cockroach ganglion.
Singh AK
Toxicol Ind Health; 1990 Dec; 6(6):551-70. PubMed ID: 2097819
[TBL] [Abstract][Full Text] [Related]
17. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase-capped Mesoporous Silica Nanoparticles Controlled by the Presence of Inhibitors.
Pascual L; El Sayed S; Marcos MD; Martínez-Máñez R; Sancenón F
Chem Asian J; 2017 Apr; 12(7):775-784. PubMed ID: 28169488
[TBL] [Abstract][Full Text] [Related]
19. Discovery of non-oxime reactivators using an in silico pharmacophore model of reactivators for DFP-inhibited acetylcholinesterase.
Bhattacharjee AK; Marek E; Le HT; Ratcliffe R; DeMar JC; Pervitsky D; Gordon RK
Eur J Med Chem; 2015 Jan; 90():209-20. PubMed ID: 25461321
[TBL] [Abstract][Full Text] [Related]
20. Postnatal diisopropylfluorophosphate enhances conditioned vigilance in adult BALB/c and C57BL/6 mice and alters expression of acetylcholinesterase splice variants.
Oriel S; Dori A; Kofman O
Behav Pharmacol; 2014 Oct; 25(7):661-72. PubMed ID: 25171079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
